CA
NZ
UK
AU
IND
US
Perrigo (NYSE:PRGO) is a Dublin, Ireland-headquartered consumer self-care company founded in 1887, recognized as the largest store-brand over-the-counter provider in the United States and a top 10 OTC company in Europe. Operating through its Consumer Self-Care Americas and Consumer Self-Care International segments, the company …
Twist Bioscience (NASDAQ:TWST) is a South San Francisco-based synthetic biology company founded in 2013 that has developed a proprietary silicon-based DNA synthesis platform, enabling high-throughput, cost-effective manufacturing of synthetic DNA at unprecedented precision and scale. The company offers a broad portfolio of products and …
Tyra Biosciences (NASDAQ:TYRA) is a clinical-stage biotechnology company headquartered in Carlsbad, California, focused on developing next-generation therapies that target Fibroblast Growth Factor Receptor biology to overcome tumor resistance and improve patient outcomes. Its lead candidate, dabogratinib, TYRA-300, is a highly selective FGFR3 inhibitor in …
UroGen Pharma (NASDAQ:URGN) is a Princeton, New Jersey-based biotechnology company focused on developing and commercializing innovative solutions for urothelial and specialty cancers, leveraging its proprietary RTGel reverse-thermal hydrogel technology platform. The company's commercial portfolio includes JELMYTO, the first and only FDA-approved non-surgical treatment for …
Amgen (NASDAQ:AMGN) is a leading global biotechnology company founded in 1980 and headquartered in Thousand Oaks, California, dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Its extensive product portfolio spans oncology and hematology, inflammatory diseases, bone health, cardiovascular disease, nephrology, and neuroscience, …
Bioventus (NASDAQ:BVS) is a Durham, North Carolina-based medical device company that develops and commercializes clinically proven, cost-effective, and minimally invasive treatments to help relieve pain and support musculoskeletal healing. Its product portfolio spans three verticals, Pain Treatments, Restorative Therapies, and Surgical Solutions, including hyaluronic …
Bristol-Myers Squibb Company (NYSE:BMY) is a leading global biopharmaceutical company headquartered in New York City, dedicated to discovering, developing, manufacturing, and commercializing innovative medicines across oncology, hematology, cardiovascular disease, immunology, and neuroscience. The company's diversified portfolio includes major products such as Eliquis, Reblozyl, Opdivo, …
Danaher (NYSE:DHR) is a leading global science and technology innovator headquartered in Washington, D.C., dedicated to accelerating the power of science and technology to improve human health. The company operates through its Biotechnology, Life Sciences, and Diagnostics segments, offering support product discovery, development, and …
Gilead Sciences (NASDAQ:GILD) is a global biopharmaceutical company headquartered in Foster City, California, that discovers, develops, and commercializes innovative medicines addressing areas of unmet medical need. Its core therapeutic franchises include HIV/AIDS treatments (Biktarvy, Genvoya, Descovy, Truvada), liver disease therapies (Epclusa, Harvoni, Vemlidy), and …
Sight Sciences (NASDAQ:SGHT) announced it has received U.S. Food and Drug Administration 510(k) clearance for its OMNI Ultra Surgical System, indicated for canaloplasty followed by trabeculotomy to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The clearance marks the newest addition to …
Please wait processing your request...